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Abstract 
Background: Carbapenem-resistant Acinetobacter baumannii (CRAB), as one of the important causes of hospital 
acquired infections, poses a serious problem for the newborns at neonatal intensive care units (NICU). The present 
study was conducted to evaluate the prevalence of infections with CRAB at NICU at Imam Khomeini hospital in 
Tehran. Materials and Methods: The blaOXA-51-like gene was targeted among the isolates using PCR to identify 
the isolates organism at the species level. Then, susceptibility of isolates to different antibiotics was assessed using 
disc diffusion method and broth micro dilutions to determine the minimum inhibitory concentrations (MICs). Pulsed 
field gel electrophoresis (PFGE) was used for typing of isolates. Results: Totally, 10 CRAB infections were 
isolated during the 6 months study period, and all of them were positive for blaOXA-51-like gene in PCR assay.  
They were resistant to all tested antibiotics, except colistin, polymyxin B, and tigecycline. CRAB isolates had a 
high MIC values for imipenem, cefotaxime, and amikacin at NICU.  Based on the results of PFGE, 3 pulsotypes 
including clone A (7%), clone B (2%), and clone D (1%) were seen in the 10 CRAB isolates. Clone A was a 
dominant clone and spread in different wards of the hospital, especially in other ICUs and the emergency ward. 
Conclusion: Based on the results of this study, CRAB infection, with a high resistance rate, has the ability to enter 
into important wards such as NICU, and thus it is highly important to control the presence of these isolates in 
different parts of the hospital. Moreover, the similarity between the pulsotypes showed the ability of transferring 
CRAB infection from different wards of the hospital to the NICU. 
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The infants who are cared at NICU in 
hospitals are at high risk for various types of 
nosocomial infections due to insufficiency of the 
immune system (1). Acinetobacter spp.  is a non-
fermentative, gram-negative, opportunistic, aerobic, 
polymorphic, and non-motile bacterium. 
Acinetobacter baumannii (A. baumannii) is the most 
important cause of nosocomial infections worldwide 
and is ranked second after Pseudomonas aeruginosa 
among different bacteria with hospital infection ability 
(2, 3, 4). The Centers for Disease Control and 
Prevention (CDC), reported A. baumannii in about 
80% of Acinetobacter infections in the USA in 2004. 
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A. baumannii is able to enter the body through open 
wound, catheter, and respiratory tract, causing major 
diseases such as pneumonia, meningitis, endocarditis, 
urinary tract infections, and burn infections, 
especially in the intensive care units (ICUs) and 
surgery ward, and among burn and dialysis patients 
(3, 5-7). Although A. baumannii is known as a 
nosocomial pathogen in adults, it is also highly 
important in developing these infections in newborns 
(6). More than 25% of people have this bacterium as 
a normal flora on their skin surface, and this 
bacterium can spread through the infected hands of 
the hospital staff between different parts of the 
hospital (7). The extensive dissemination ability of 
A. baumannii in hospital environments by persisting 
on hospital equipments in dry and wet environments, 
such as soaps, anti-infectious and antiseptic agents, 
and also its ability to produce biofilms and use 
various metabolic sources can lead to its long-term 
survival (2, 8, 14). Another important reason for the 
establishment and incidence of bacterial infections in 
important wards, such as NICU, is the ability of this 
bacterium to acquire resistance to multiple 
antibiotics, in addition to its intrinsic resistance. Over 
the past 2 decades, multidrug resistant A. baumannii 
(MDR A. baumannii), which is resistant to at least 3 
antibiotic classes including cephalosporins, 
fluoroquinolones, and aminoglycosides, has been 
developed due to the overuse of broad-spectrum 
antibiotics in hospitals. Now a days, resistance to this 
bacterium is defined in various classes of MDR,  
extensively drug resistant (XDR), which is resistant 
to all available antimicrobial drugs other than colistin 
and polymyxin B, and pan-drug resistant (PDR), 
which is practically resistant to all antibiotics (9,10, 
11). Until 1991, carbapenems were the preferred 
drug for the treatment of MDRAB (12, 13).  CRAB 
isolates are developed by several factors including 
enzymatic inactivation by beta-lactamases, loss of 
outer membrane purins, changes in penicillin-binding 
protein (PBP), and specific drug delivery pumps. 
Seven phylogenic subgroups of oxalocylinases with 
carbapenem ligation activity were identified by 
CHDLs (Class D Ampler) (14, 15). 
Septicemia induced by AB is one of the major 
causes of infant mortality in developing countries in 
NICUs. In India, the incidence of neonatal 
septicemia was 30 per 1000 live births (5). Several 
studies have been done on CRAB in hospitals, but 
limited studies have been conducted on the presence of 
this bacterium in the NICU and its resistance to 
various antibiotics at this ward. Therefore, in this 
study, the multi drug resistance of CRAB to antibiotics 
was investigated at NICU of Imam Khomeini hospital, 
Tehran, Iran. 
Methods 
Clinical Specimens. Different clinical 
specimens (blood, wound, urine, stool, and sputum) 
were collected from the NICU of Imam Khomeini 
hospital during 9 months. To ensure the accuracy of 
selecting A.baumannii isolates, the followings assays 
were performed: microscopic examination and culture 
in the eosin methylene blue; and biochemical tests 
(including aerobic and anaerobic OF test, lactose, 
triple Sugar iron agar (TSI), and IMVIC (Indole 
(SIM), movement (SIM), methyl red (MR), and 
Voges-Proskauer (VP), and simon citrate) (Merck, 
Germany)). Then, CRAB isolates were randomly 
selected from A. baumannii isolates (16). 
Identification of the blaOXA-51- like Gene Using 
PCR. PCR method was used to confirm the 
identification of the isolates. For this purpose, DNA of 
CRAB isolates was extracted by boiling method; 
moreover, 5'-TAA TGC TTT GAT CGG CCT TG-3 ' 
and 5'-TGG ATT GCA CTT CAT CTT GG-3 '  
forward, and reverse primers (353bp) (Sina gene, Iran) 
were, respectively, used as specific primers to detect 
blaOXA-51 like gene. A. baumannii NCTC 12156 
reference strain was used as a positive control for the 
blaOXA-51-like gene. Furthermore,1% agarose gel 
(Fermentas) was used for electrophoresis of PCR 
products. After identification, isolates were store at -
70 ° C in the trypticase soy broth and glycerol until 
used (15, 17).  
Determining the Susceptibility of Isolates to 
Antibiotics by Disc Diffusion (Kirby-Bauer) Method 
 Inoculums samples equivalent to 0.5 MC 
Farland turbidity were prepared and cultured on the 
surface of the solid medium with a swab. Kirby Bauer 
disk diffusion method was used to assess the 
susceptibility of isolates to various classes of 
antibiotics including gentamicin (10 µg), amikacin (30 
µg), ampicillin (10 µg), ampicillin/sulbactam (20 µg), 
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trimethoprim/sulfamethoxazole (25 µg), 
piperacillin/tazobactam (100/10 µg), tetracycline (30 
µg), ticarcillin (75µg), ticarcillin/clavulanic acid 
(75/10 µg), tobramycin (10 µg), netilmicin (30 µg), 
cefepime (30 µg) cefotaxime (30 µg), ceftazidime 
(30 µg), ceftriaxone (30 µg), ciprofloxacin (5 µg), 
levofloxacin (5 µg), ofloxacin (5 µg),  meropenem 
(10 µg), imipenem (10 µg), doripenem (10 µg), 
doxycycline (30 µg), minocycline (30 µg), 
tigecycline (10 µg), colistin (10 µg), and polymyxin B 
(300 unit) (MAST, Merseyside, U.K). The plates were 
incubated for 16 to 18 hours at 37° C. The diameters 
of inhibitory zones were measured according to the 
CLSI guidelines. To control the quality of the discs on 
the Muller Hinton Agar, Escherichia coli (ATCC 
25922), Pseudomonas aeruginosa (ATCC 27853), and 
Klebsiella pneumoniae (ATCC 13883) were used (18).  
 
Table1: Resistant of CRAB isolates to different antibiotics 
Antibiotics Sensitive Intermediate Resistant 
Gentamicin 0 0 10 
Tobramycin 0 0 10 
Amikacin 0 0 10 
Netilmicin 0 0 10 
Imipenem 0 0 10 
Meropenem 0 0 10 
Doripenem 0 0 10 
Ciprofloxacin 0 0 10 
Levofloxacin 0 0 10 
Ofloxacin 0 0 10 
Piperacillin/tazobactam 0 0 10 
Ticarcillin 0 0 10 
Ticarcillin/clavulanic 0 0 10 
Cefotaxime 0 0 10 
Ceftriaxone 0 0 10 
Ceftazidime 0 0 10 
Cefepime 0 0 10 
Trimethoprim/sulfamethoxazole 0 0 10 
Ampicillin 0 0 10 
Ampicillin/Sulbactam 0 2 8 
Colistin 10 0 0 
Polymyxin B 10 0 0 
Tetracycline 0 0 10 
Doxycycline 0 0 10 
Minocycline 0 2 8 
Tigecycline 8 2 0 
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Determining the MIC of Antibiotics by Micro 
broth Dilution Method. The powder of amikacin, 
ampicillin-sulbactam, imipenem, meropenem, and 
colistin (Sigma Aldrich, Germany) were used. At 
first, antibiotic storage solutions were prepared based 
on the potency of antibiotic powder using the 
following formula: 
 
A spectrum of 0.625- 1280 for amikacin and 
ampicillin/sulbactam, and a spectrum of 0/15625-
1280 for imipenem and meropenem were used for 
colistin. Pseudomonas aeruginosa (ATCC 27853) 
and Escherichia coli (ATCC 25922) were used as 
control microorganisms (18). 
MIC50 and MIC90 Detection. The 
concentration of MIC, which inhibits 50% and 90% 
of isolates, was considered as MIC50 and MIC90, 
respectively. For this purpose, the obtained MICs of 
antibiotic powders were arranged from low to high 






 for MIC50 and MIC90, 
respectively (number of samples = n) (18). 
Pulsed Field Gel Electrophoresis. Typing of 
the randomly collected CRAB from different wards of 
the hospital was done using Durmazet al. methods 
using Field Inversion Gel Electrophoresis (FIGE). The 
ApaI (Thermo scientific) endonuclease was used for 
digestion of pure genomic DNA. DNA of lambda 
phage ladder (New England Biolab) was used as a 
marker, and Gel Compare II Version 6.5 was used to 
analyze the clones (19, 20). 
Results 
During this study, 10 samples of CRAB were 
collected from the NICU of Imam Khomeini hospital. 
All isolates were cultured from female patients, 5 
samples from trachea and 5 from the blood. All CRAB 
Table2: The  MIC50 and MIC90 Values of CRAB 
Antibiotics MIC 50 µg/ml MIC 90 µg/ml Range µg/ml MODE µg/ml 
Imipenem 1280 1280 0.625-1280 1280 
Meropenem 80 320 0.625-1280 40 
Cefotaxime 640 1280 0.625-1280 640 
Amikacin 1280 1280 0.625-1280 1280 
Colistin 0.3 0.83 0.15625-1280 0.16 
Ampicillin/
Sulbactam 
80 160 0.625-1280 80 
 
Table3: The relationship of PFGE clones and different cliniclal specimens. 
                                     cliniclal specimens 
 clones 
Blood Trachea 
Clone A 5 2 
Clone B - 2 
Clone D 1 - 
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isolates were resistant to the used antibiotics except 
to colistin, polymyxin B, and tigecycline (table 1). 
According to Table 1, all isolates of CRAB were 
MDR and XDR, and none was PDR. 
According to table 2, colistin and 
ampicillin/sulbactam and meropenem showed the 
lowest MIC levels, but, cefotaxime, ampicillin, and 
amikacin showed the highest. The PFGE results 
revealed that 7 isolates belonged to clone A, 2 to 
clone B, and 1 to clone D, respectively. The most 
isolates of clones were collected from trachea and the 
single isolate in clone D was isolated from blood 
(table 3). All isolates were susceptible to colistin and 
polymyxin.  
Discussion 
In the present study, 10 CRAB isolates were 
collected at NICU of Imam Khomeini hospital in 
Tehran, Iran, from September 2015 to June 2016.  
Touati et al. stated that A. baumannii isolates, which 
are responsible for NICU infection, are often 
resistant to imipenem, and they further revealed that 
the presence of these isolates cause problems for 
other therapeutic pathways. Studies have shown that 
CRAB isolates are responsible for the incidence of 
this bacterium compared with sporadic cases (14). 
Several studies have reported that the use of 
respirator and intravenous catheters in NICU cause 
high persistence of these bacteria at NICU (7).  
Touati et al. have stated that the mortality rate due to 
A. baumannii infections in neonates is 13.9% to 38% 
and Wei et al. reported that the mortality rate due to 
MDR A. baumannii sepsis was 20.34%  from 59 
neonatal patients in a hospital in Taiwan, signifying 
the importance of  the infection with A. baumannii 
isolates in the NICU (7, 14). At present study the 
blaOXA-51-like gene was detected among all the 
studied CRAB isolates. Turton et al. (2006) stated 
that finding blaOXA-51-like in  A. baumannii 
isolates is a reliable way to identify the organism at 
species level (15). In this study, NICU samples were 
obtained from blood and respiratory tract of infants. 
Wei et al., in their study on MDR A. baumannii  
found that 56.72%, 88.23%, 10.45%, 4.48%, and 
2.99% of the isolates were collected from blood, 
sputum, pus, ascites, spinal cord, and fluid, 
respectively. Moreover, they indicated that one of the 
isolates that belonged to plural fluid showed the 
highest number of isolates and was recovered from the 
blood and the respiratory tract (7). Several studies 
demonstrated that the risk factors for CRAB infection 
in NICU include low gestational age, preterm birth, 
low birth weight infants, infants with less than 7 days 
age, hospitalization time of more than 7 days, use of 
invasive devices (such as vascular catheters and 
artificial respiration), and  use of imipenem (1, 7, 14, 
21). Due to the inherent ability of this bacterium to 
remain on the surfaces and equipment of the hospital, 
CRAB can also gain the ability to be distributed in 
different wards of the hospital. According to PFGE 
analysis of the NICU, the collected isolates belonged 
to clones A, B, and D (7%, 2%, and 1%). Isolates 
within Clone A have also been found at other ICUs 
and emergency ward of Imam Khomeini Hospital, 
indicating that these bacteria can spread to different 
wards. In Michigan (2008- 2009), McGrath et al. 
studied 6 low weight infants with PFGE. They stated 
that the employees who had contacts with infants 
could transfer the CRAB to the NICU (22). Melamed 
et al., in their study of A. baumannii outbreak at NICU 
with PFGE, concluded that a rapid investigation for 
outbreak of A. baumannii is essential to find the 
source of infection (23). In a study conducted by a 
control team at one of the hospitals in China, the areas 
that have a higher risk for NICU deployment of MDR 
A.baumannii including NICU doors, incubator 
windows, incubator control panels, artificial 
respiration, electrocardiogram monitoring, device 
buttons suction, computer keyboard, ultrasound 
apparatus for breast, and bed infants were investigated 
(7). The results of a study in France revealed that the 
preparation of the antibiotic susceptibility pattern for 
all newborns who have developed A. baumannii is 
essential to prevent the spread and incidence of 
infections in all NICUs in the hospital (14). Thus, in 
this study, the CRAB isolates resistance pattern to 
different antibiotics was studied. According to the 
results of this study, the most effective antibiotics 
were colistin, polymyxin B, and tigecycline. 
Moreover, all CRAB isolates obtained from the NICU 
were sensitive to colistin and polymyxinB, 8 isolates 
were susceptible to tigecycline, and all isolates were 
resistant to the rest of the used antibiotics.  Also, 
among the 6 antibiotics used in the MIC in this study, 
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colistin and ampicillin/sulbactam and meropenem 
had the lowest levels of MIC values, and cefotaxime, 
ampicillin, and amikacin had the highest. These 
results indicated that CRAB isolates were even 
resistant to highest doses of these antibiotics. 
In this study, all CRAB isolates were MDR 
and XDR, and none of the isolates were PDR. 
Several studies have revealed that previous use of 
third-generation cephalosporins, fluoroquinolones, 
and carbapenems are effective in the development of 
MDR A. baumannii strains (21, 24). Also, in Taiwan 
(2010 to 2013), Wei et al. investigated the microbial 
resistance of A. baumannii isolates at the NICU 
ward, and they found that from 67 studied isolates, 
all were MDR A. baumannii, and most isolates were 
just sensitive to colistin and tigecycline (7). Zarrilli et 
al. in a study in Italy (2012) on XDR A. baumannii 
isolates of NICU concluded that A. baumannii 
isolates were resistant to aminoglycosides, 
quinolones, and beta-lactams, but they were only 
sensitive to colistin and tigecycline (21). 
Jaroush et al. (2004) studied the resistant 
patterns of A. baumannii isolates that were diverted 
from 579 blood samples of 2 NICUs in 2 hospitals in 
Gaza, Palestine. They found that A. baumannii 
isolates were resistant to antibiotics that were 
commonly used in those hospitals, while their 
sensitivity to meropenem, imipenem, ciprofloxacin, 
gentamicin, and ceftriaxone was 92.5%, 90%, 75%, 
5.75%, and 50%, respectively. Moreover, in the 
present study, A. baumannii isolates were resistant to 
commonly used antibiotics in Imam Khomeini 
hospital, but the resistance patterns of A. baumannii 
isolates in Palestine were completely different from 
those of the present study. 
In fact, their results indicated that imipenem 
and meropenem were effective antibiotics against A. 
baumannii isolates. However, sensitivity of the third 
and fourth genera and ciprofloxacin to cephalosporin 
was different, which is why despite the fact that 
ciprofloxacin is not prescribed for treatment of 
neonates; these hospitals have to use this antibiotic 
due to lack of suitable substitutes. They also found 
that 37.5% of MDR A. baumannii, which are caused 
by the uncontrolled consumption of antibiotics, are 
used to prevent and treat infants (1). 
Based on the results of this study, to prevent 
the presence of highly resistant A. baumannii isolates, 
especially in important wards such as NICU that 
provide very little treatment, implementing monitoring 
programs, such as evaluating multiple antibiotic 
resistance of isolates and calculating antibiotic MIC 
levels, are of paramount importance. 
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